GSDMD and atherosclerosis: Given that GSDMD is principally distributed in macrophages during atherosclerosis,13 we constructed macrophage membrane‐coated GI‐Y2 nanoparticles (GI‐Y2@MM‐NPs) to enhance the targeting of GI‐Y2 to macrophages in atheromatous plaques.